Insider Buying: InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) CFO Buys 3,000 Shares of Stock

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFUGet Free Report) CFO Barry G. Steele bought 3,000 shares of the business’s stock in a transaction that occurred on Monday, May 20th. The stock was acquired at an average cost of $6.47 per share, for a total transaction of $19,410.00. Following the completion of the purchase, the chief financial officer now directly owns 70,195 shares of the company’s stock, valued at $454,161.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

InfuSystem Price Performance

Shares of INFU opened at $7.14 on Thursday. InfuSystem Holdings, Inc. has a one year low of $6.25 and a one year high of $11.44. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.57.

Institutional Trading of InfuSystem

Hedge funds and other institutional investors have recently modified their holdings of the business. WINTON GROUP Ltd purchased a new position in shares of InfuSystem during the third quarter valued at approximately $101,000. Vanguard Group Inc. grew its position in InfuSystem by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 1,083,730 shares of the medical instruments supplier’s stock valued at $9,288,000 after purchasing an additional 18,432 shares during the last quarter. Wasatch Advisors LP increased its stake in InfuSystem by 3.4% during the 4th quarter. Wasatch Advisors LP now owns 846,609 shares of the medical instruments supplier’s stock valued at $8,923,000 after purchasing an additional 27,881 shares in the last quarter. Citigroup Inc. raised its holdings in InfuSystem by 124.1% in the third quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier’s stock worth $488,000 after buying an additional 28,038 shares during the last quarter. Finally, Ranger Investment Management L.P. lifted its stake in shares of InfuSystem by 4.7% in the fourth quarter. Ranger Investment Management L.P. now owns 689,842 shares of the medical instruments supplier’s stock worth $7,271,000 after buying an additional 30,835 shares in the last quarter. 71.13% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. StockNews.com lowered InfuSystem from a “strong-buy” rating to a “buy” rating in a research report on Monday, May 13th. Lake Street Capital raised shares of InfuSystem to a “strong-buy” rating in a research report on Thursday, May 9th.

Read Our Latest Report on InfuSystem

InfuSystem Company Profile

(Get Free Report)

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

See Also

Insider Buying and Selling by Quarter for InfuSystem (NYSEAMERICAN:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.